FDA-Approved vs FDA-Cleared vs FDA-Registered: The Aesthetic Device Marketing Distinction That's Costing Clinics Warning Letters

There are three distinct FDA statuses that aesthetic practice marketing regularly conflates: FDA-approved, FDA-cleared, and FDA-registered. They mean different things, have different evidentiary bases, and carry different marketing implications. Using them interchangeably - which almost every aesthetic practice does - is both factually wrong and a specific FDA enforcement pattern. This is the full breakdown of what each term means, which one applies to which equipment, and how to describe your devices in marketing accurately.

The distinction is not pedantic. FDA warning letters in the aesthetic device space specifically cite misuse of these terms as a deceptive-advertising basis. Getting them right is a one-time edit to your website, ad copy, and staff training that eliminates a surprisingly common compliance gap.

The three statuses, clearly distinguished

FDA-approved

FDA approval is the highest-evidence pathway. It applies to products that have gone through a Premarket Approval (PMA) for devices, or a New Drug Application (NDA) for drugs. Approval requires clinical evidence of safety and efficacy for the specific indications claimed. Most prescription drugs and high-risk (Class III) medical devices go through this pathway.

Examples relevant to healthcare practices: Botox Cosmetic (approved for specific glabellar-line indications), many dermal fillers (approved for specific soft-tissue augmentation indications), some surgical lasers for specific clinical indications.

FDA-cleared (510(k) clearance)

510(k) clearance is the most common pathway for medical devices. A device can be cleared if it’s substantially equivalent to an existing legally-marketed device (the “predicate”). Clearance requires demonstration of substantial equivalence rather than independent clinical evidence of safety and efficacy. Most Class I and Class II medical devices go through this pathway.

Examples relevant to healthcare practices: most aesthetic lasers, most RF devices, most microneedling platforms, most body-contouring equipment, intraoral scanners, many diagnostic devices.

FDA-registered

FDA registration is an entirely different concept - it refers to the facility or establishment that manufactures, processes, packs, or distributes a product, not the product itself. Registration is a regulatory filing confirming the facility exists and operates under FDA jurisdiction. It is not an endorsement, approval, or clearance of anything the facility produces.

Examples: tissue banks and HCT/P processors register with the FDA under 21 CFR Part 1271. Drug and device manufacturers register their facilities. Healthcare practices themselves typically are not FDA-registered because they are not manufacturing establishments.

The typical mistakes in aesthetic marketing

Mistake 1: “FDA-approved” applied to cleared devices

Mistake 2: “FDA-approved” for off-label uses

Mistake 3: “FDA-registered facility” as endorsement

Mistake 4: Mixing terms across a single marketing surface

Websites that use “FDA-approved” on the homepage, “FDA-cleared” on the device detail page, and “FDA-registered” in the staff bios - all describing the same piece of equipment - create an internal inconsistency that itself flags poor compliance. The FDA reads the entire surface, and inconsistency is a visible pattern.

How to describe specific device categories

Aesthetic lasers (CO2, Fraxel, IPL, etc.)

Typically FDA-cleared. Describe as “FDA-cleared for [specific indication, such as wrinkle treatment, hair removal, pigmentation].” Name the specific device when feasible (“our Fraxel Dual laser”).

RF (radiofrequency) devices (Thermage, Morpheus8, etc.)

Typically FDA-cleared. Describe as “FDA-cleared for [specific indication].” RF devices have specific cleared indications and marketing for off-label applications is a common compliance issue.

Ultrasound devices (Ultherapy, etc.)

Typically FDA-cleared for specific indications. Describe accurately per device labeling.

Body-contouring devices (CoolSculpting, EMSculpt, etc.)

Typically FDA-cleared. Describe as “FDA-cleared for [specific body area indications].” These devices often have indication-specific clearances and using them for unapproved body areas is a common off-label marketing pattern.

Neurotoxins (Botox, Dysport, Xeomin, Jeuveau, Daxxify)

FDA-approved prescription drugs. Describe accurately with approved indications - glabellar lines, forehead lines, lateral canthal lines, depending on the specific product and FDA approval status. Marketing for off-label indications (masseter, jawline, chin) is a specific enforcement pattern.

Dermal fillers (Juvederm, Restylane, Belotero, Radiesse, Sculptra, Bellafill)

FDA-approved medical devices. Describe accurately with approved indications. Most fillers have indication-specific approvals (nasolabial folds, lip augmentation, cheek augmentation, etc.) and marketing outside those approvals is off-label promotion.

PRP (platelet-rich plasma)

Centrifuge systems for PRP preparation are typically FDA-cleared as general centrifuge equipment, not FDA-approved for specific therapeutic applications. The PRP preparation itself is typically considered an HCT/P operating under the 361 pathway. Describe accurately - “PRP prepared in our FDA-cleared centrifuge system” is fine; “FDA-approved PRP treatment” is not.

HCT/P products (stem cells, amniotic tissue, exosomes, etc.)

HCT/P products operating under the 361 pathway do not require FDA pre-market approval; they are regulated but not approved. Describe accurately - “our HCT/P products are provided by FDA-registered tissue processors under the 361 pathway” is compliant; “FDA-approved stem cells” is not.

Platform ad policies add a layer

Google Ads, Meta, and TikTok have their own healthcare advertising policies that typically track FDA rules but add additional layers. Meta’s advertising policies, for instance, restrict certain before/after imagery and restrict claims about specific device-based treatments. Running ads with “FDA-approved” claims for FDA-cleared devices can result in ad disapproval or account-level action on top of FDA regulatory exposure.

A practical audit you can run this week

Here’s the quickest possible audit of this specific compliance issue across your marketing:

1. Search your website for the phrase “FDA-approved” - list every page where it appears.
2. For each appearance, determine whether the product is actually FDA-approved or FDA-cleared or neither. Most aesthetic lasers and RF devices are cleared, not approved.
3. Search for “FDA-registered” and “FDA-cleared” - verify each is applied to the correct thing (facility vs device).
4. Do the same search across your social media, ad copy, and staff bios.
5. Update every inaccurate reference. Use specific device names and specific approved indications where possible - vagueness reads as hiding something.

This is the single highest-ROI compliance audit a med spa can run. It takes an afternoon, costs nothing, and closes one of the most reliable enforcement patterns in aesthetic device marketing. Yet most practices have never done it.

Frequently asked questions

Is saying “FDA-cleared” enough on its own?

More compliant than “FDA-approved,” but specificity helps more: “FDA-cleared for [specific indication]” is stronger than just “FDA-cleared” because it avoids the implication that the clearance covers whatever you happen to use the device for.

Can I cite the 510(k) number?

Yes. Citing the specific K-number (e.g., “K123456”) and the cleared indications is the gold standard for device-marketing accuracy. It’s verifiable, specific, and demonstrates genuine regulatory literacy.

What if the manufacturer’s marketing uses “FDA-approved” loosely?

Manufacturers sometimes use loose terminology in their clinic- facing marketing that does not hold up in consumer-facing marketing. Your obligation is to use the correct terminology on your own channels. Manufacturer usage is not a defense if you repeat it in your consumer marketing.

What about the phrase “FDA-acknowledged” or “FDA-recognized”?

These are not standard FDA terms and should be avoided. They create an implication of FDA endorsement without any specific regulatory meaning. Use the specific correct term (approved, cleared, or registered) or don’t make an FDA-status claim at all.

Does the distinction matter for consumer patients?

From a patient-decision perspective, the distinction between approved and cleared is technical. From a regulatory-compliance perspective, it’s the difference between compliant and non-compliant advertising. The FDA and patient understanding operate on different frames - but only the FDA perspective determines whether you receive a warning letter.

What about combining “FDA-cleared device” with off-label use?

“FDA-cleared device used for [off-label application]” is accurate to the device status but the off-label application itself creates a separate marketing issue. Clinicians can appropriately use devices off-label; marketing those off-label uses is a separate compliance layer. The cleanest approach is to describe the procedure/service rather than specific off-label device uses.